4% for CAS and 6.34% for CEA in
1183 randomized patients. However, the study was not
powered appropriately and failed to show noninferiority
of transfemoral CAS compared with CEA (P < .09).
More recently, two large, randomized trials have been
completed. The International Carotid Stenting Study
Trial (ICST)6 enrolled 1713 patients and demonstrated
signiﬁcantly